How Important is Glycemic Control During Coronary Artery Bypass?

Advances in Surgery

Volumn 46, Issue 1, 2012, Pages 219-235

  Lazar, Harold L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass graft surgery; Diabetes mellitus; Glycemic control

Indexed keywords

GLUCOSE; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; INSULIN; POTASSIUM;

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERGLYCEMIA; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; MYOCARDIAL ISCHEMIA; POSTOPERATIVE PERIOD; POTASSIUM; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84863426738     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2012.03.007     Document Type: Review

References (72)

1. Prevalence of the metabolic syndrome in patients with coronary heart disease, peripheral arterial disease, or abdominal aortic aneurysm. Atherosclerosis 2004, 173(2):363-369. SMART Study Group.
2. Szabo Z., Sakanson E., Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2,239 non-diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002, 74:712-719.
3. Cohen Y., Raz I., Merin G., et al. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Am J Cardiol 1998, 81:7-11.
4. Carson J.L., Scholz P.M., Chen A.Y., et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002, 40:418-423.
5. Alserium T., Hammar N., Nordquist T., et al. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J 2006, 152(3):599-605.
6. Szekely A., Levin J., Miao Y., et al. Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2011, 142:430-437.
7. Ascione R., Rogers C.A., Rajakaruna C., et al. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and non-diabetic patients undergoing cardiac surgery. Circulation 2008, 118:113-123.
8. Roques F., Nashef S.A., Michel P., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroScore multi-national database of 19,030 patients. Eur J Cardiothorac Surg 1999, 15:816-822.
9. Jacoby R., Nesto R. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992, 20:736-744.
10. Steward R.D., Lahey S.J., Levitsky S., et al. Clinical and economic impact of diabetes following coronary artery bypass. J Surg Res 1998, 76(2):124-130.
11. Herlitz J., Wognesen G.B., Emanvelsson H., et al. Mortality and morbidity in diabetic and non-diabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996, 19(7):698-703.
12. Whang W., Bigger J.T. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from the CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol 2000, 36(4):1166-1172.
13. Estrada C.A., Young J.A., Nifong L.W., et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003, 75(5):1392-1399.
14. Ferguson T.F., Hammill B.G., Peterson E.D., et al. For the STS National Database Committee. A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 2002, 73:480-490.
15. Hlatky M.A., Melson K.A., Boothroyd D.B. Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2006, 97(12A):59G-65G.
16. Opie L.H. Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 1976, 38:152-174.
17. Liv Q., Docherty J., Rendell J.C., et al. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 2002, 39:718-725.
18. Sowers J.R., Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension 1995, 26:869-879.
19. Schmidt A.M., Yan S.D., Wautier J.L., et al. Activation of receptor for advanced glycation end-points: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999, 84:489-497.
20. Viassara H. Recent progress in advanced glycation end-products and diabetic complications. Diabetes 1997, 46:519-525.
21. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor Kappa B and stimulates 1 Kappa B in mononuclear cells in obese subjects: evidence for anti-inflammatory effect. J Clin Endocrinol Metab 2001, 86:3257-3265.
22. Guerci B., Bohme P., Kearney-Schwartz A., et al. Endothelial dysfunction and type-2 diabetes. Diabetes Metab 2001, 27:436-447.
23. Park J.Y., Takahara N., Gabriele A., et al. Induction of endothelin-1 expression by glucose. An effect on protein kinase-C activation. Diabetes 2001, 49:1239-1248.
24. Verma S., Maitland A., Weisel R.D., et al. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelium antagonism. J Thorac Cardiovasc Surg 2002, 123:1120-1124.
25. Lazar H.L., Joseph L., San Mateo C., et al. Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization. J Card Surg 2010, 25:120-126.
26. Pompilio G., Rossoni G., Alamanni F., et al. Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients. Ann Thorac Surg 2001, 72:1290-1297.
27. Guzik T.S., Mussa S., Gastaldi D., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(1)H oxidase and endothelial nitric oxide synthase. Circulation 2001, 105:1656-1662.
28. Davi G., Catalan I., Averna M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990, 322:1769-1774.
29. Marfella R., Esposito K., Gionata R., et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000, 101:2247-2251.
30. Suzuka K., Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from intracellular storage site. Proc Natl Acad Sci U S A 1980, 77:2542-2547.
31. Jeschke M.G., Klein D., Javch K.W. Insulin attenuates the systemic inflammatory in endotoxemic rats. Endocrinology 2004, 145:4084-4093.
32. Langovche L., Vanhorebeek I., Vlaselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005, 115:1177-1186.
33. Johassen A.K., Sack M.N., Ejos O.D., et al. Myocardial protection by insulin at reperfusion requires early administration and is mediated via AKT and p70s6 kinase cell-survival signaling. Circ Res 2001, 89:1191-1198.
34. Gao F., Gao E., Yue E.L., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of P13-kinase, AKT, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502.
35. Svensson S., Svedjeholm R., Ekroth R. Trauma metabolism of the heart: uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg 1990, 99:1063-1073.
36. Rao V., Merante F., Weisel R.D., et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg 1998, 116:485-494.
37. Doenst T., Wiseysundera D., Karkouti K., et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005, 130:1140-1150.
38. Fish L.H., Weaver T.W., Moore A.L., et al. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am J Cardiol 2003, 92:74-76.
39. McAlister F.A., Man J., Bistritz L., et al. Diabetes and coronary artery bypass surgery. Diabetes Care 2003, 26:1518-1524.
40. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005, 80:862-866.
41. Anderson R.E., Klerdal K., Ivert T. Fasting blood glucose and mortality after coronary artery bypass graft surgery. Eur Heart J 2005, 26:1513-1518.
42. Imran S.A., Ransom T.B., Bluth K.R., et al. Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery. Can J Cardiol 2010, 26:151-154.
43. Duncan A.E., Abd-Elsayed A., Maheshwari A., et al. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010, 112:860-871.
44. Sodi-Pollares D., Testelli M.D., Fisleder B.L., et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1965, 5:166-181.
45. Medical Research Council Working Party Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet 1968, 2:1355-1360.
46. Lazar H.L., Zhang X., Rivers S., et al. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg 1995, 60:411-416.
47. Lazar H.L., Philippides G., Fitzgerald C., et al. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997, 113:354-362.
48. Quinn D.W., Pagano D., Bonser R.S., et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 2006, 131:34-42.
49. Koskenkark J.K., Kaukoranta P.K., Kivilvoma K.T., et al. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 2005, 80:511-517.
50. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57-65.
51. Prospective, randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997, 314:1512-1515. DIGAMI Study Group.
52. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109:1497-1502.
53. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:1007-1021.
54. Furnary A., Wu Y., Bookin S. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland diabetic project. Endocr Pract 2004, 10(Suppl 2):21-33.
55. Golden S.H., Peart-Vigilance C., Kao W.H., et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999, 22:1408-1414.
56. Kerr K., Furnary A., Grunkemeier G., et al. Glucose control lowers the risk of wound infections in diabetics after open heart operations. Ann Thorac Surg 1997, 63:356-361.
57. Hruska L.A., Smith J.M., Hendy M.P., et al. Continuous insulin infusion reduces infectious complications in diabetes following coronary surgery. J Card Surg 2005, 20:402-407.
58. Rassias A.J., Marrin C.A., Arruda J., et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg 1999, 88:1011-1016.
59. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
60. D'Allessandro C., Leprince P., Golmard J.L., et al. Strict glycemic control reduces EuroScore expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007, 134:29-37.
61. Butterworth J., Wagenknecht L.E., Legault C., et al. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2005, 130:1319-1325.
62. Gandhi G.Y., Nuttall G.A., Abel N.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 2007, 146:233-242.
63. Lazar H.L., McDonnell M., Chipkin S., et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009, 87:663-669.
64. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
65. Preiser J.C., Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med 2007, 35:S503-S507.
66. Gerstein H.C., Miller M.E., Byinton R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
67. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1993, 352:854-865. The UK Prospective Diabetes Study (UKPDS) Group.
68. Patel A., MacMahond A., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. Advance Collaborative Group.
69. Zoungas S., Patel A., Chalmers J., et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010, 363:1410-1416. The ADVANCE Collaborative Group.
70. Lazar H.L., McDonnell M., Chipkin S., et al. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg 2011, 254(3):458-464.
71. Bhamidipati C.M., LaPar D.J., Stukenborg G.J., et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2010, 141:1-9.
72. Qaseem A., Humphrey L.L., Chou R., et al. For the Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients. A clinical practice guideline fro American College of Physicians. Ann Intern Med 2011, 154:260-267.